Leading Pharmaceutical Innovation
Trends and Drivers for Growth in the Pharmaceutical Industry
(Sprache: Englisch)
This book focuses on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Leider schon ausverkauft
versandkostenfrei
Buch (Gebunden)
76.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Leading Pharmaceutical Innovation “
This book focuses on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Klappentext zu „Leading Pharmaceutical Innovation “
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Inhaltsverzeichnis zu „Leading Pharmaceutical Innovation “
- Innovation: Key to Success in the Pharmaceutical Industry- The Industry Challenge: Do You Really Want to Be in This Business?- The Science and Technology Challenge: How to Find New Drugs
- The Pipeline Management Challenge: How to Organize Innovation
- The Internationalization Challenge: Where to Get Access to Innovation
- Management Answers to Pharmaceutical R&D Challenges
- Future Directions and Trends
Autoren-Porträt von Oliver Gassmann, Gerrit Reepmeyer, Max von Zedtwitz
Prof. Dr. Oliver Gassmann ist Professor für Technologiemanagement und Direktor des Instituts für Technologiemanagement an der Universität St. Gallen.
Bibliographische Angaben
- Autoren: Oliver Gassmann , Gerrit Reepmeyer , Max von Zedtwitz
- 2008, 2nd ed., 186 Seiten, 47 Abbildungen, Maße: 16 x 24,1 cm, Gebunden, Englisch
- Verlag: Springer
- ISBN-10: 3540776354
- ISBN-13: 9783540776352
- Erscheinungsdatum: 03.03.2008
Sprache:
Englisch
Rezension zu „Leading Pharmaceutical Innovation “
From the reviews:"This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies ... . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies ... . The six-page glossary of industry terms, when used with its decent index, is a particular joy. ... recommend this offering to prospective managers and researchers in this industry ... ." (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005)
From the reviews of the second edition:
"Leading Pharmaceutical Innovation, Gassmann and colleagues describe the current status of the pharmaceutical industry ... . This book comprises seven chapters, where each could be seen as a review of the addressed topic. This helps with understanding the complexity of the challenges the pharmaceutical industry is facing, in comparison to the automotive industry or with respect to marketing problems ... . book provides most valuable insight into the pharmaceutical industry from an 'outsiders' perspective." (Sandrine Shepard and Thomas Wilckens, R&D Management, Vol. 40 (5), November, 2010)
Kommentar zu "Leading Pharmaceutical Innovation"
Schreiben Sie einen Kommentar zu "Leading Pharmaceutical Innovation".
Kommentar verfassen